Advertisement

Immunologic Research

, Volume 64, Issue 4, pp 1013–1024 | Cite as

Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans

  • Chengjie Shu
  • Lingmei Sun
  • Weiming ZhangEmail author
Original Article

Abstract

The Caenorhabditis elegans model can be used to study Candida albicans virulence and host immunity, as well as to identify plant-derived natural products to use against C. albicans. Thymol is a hydrophobic phenol compound from the aromatic plant thyme. In this study, the in vitro data demonstrated concentration-dependent thymol inhibition of both C. albicans growth and biofilm formation during different developmental phases. With the aid of the C. elegans system, we performed in vivo assays, and our results further showed the ability of thymol to increase C. elegans life span during infection, inhibit C. albicans colony formation in the C. elegans intestine, and increase the expression levels of host antimicrobial genes. Moreover, among the genes that encode the p38 MAPK signaling pathway, mutation of the pmk-1 or sek-1 gene decreased the beneficial effects of thymol’s antifungal activity against C. albicans and thymol’s maintenance of the innate immune response in nematodes. Western blot data showed the level of phosphorylation of pmk-1 was dramatically decreased against C. albicans. In nematodes, treatment with thymol recovered the dysregulation of pmk-1 and sek-1 gene expressions, the phosphorylation level of PMK-1 caused by C. albicans infection. Therefore, thymol may act, at least in part, through the function of the p38 MAPK signaling pathway to protect against C. albicans infection and maintain the host innate immune response to C. albicans. Our results indicate that the p38 MAPK signaling pathway plays a crucial role in regulating the beneficial effects observed after nematodes infected with C. albicans were treated with thymol.

Keywords

Thymol Candida albicans Immunity Caenorhabditis elegans 

Notes

Acknowledgments

This study was supported by the National Program during the 12th Five-year Plan Period, high ecological utilization for regional specialty resources (2012BAD36B01), Grants from the National Natural Science Foundation of China (No. 81302814), and Natural Science Foundation of Jiangsu Province (No. BK20130640).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights statement

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–28.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Berman J, Sudbery PE. Candida Albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet. 2002;3(12):918–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Kobayashi SD, Cutler JE. Candida albicans hyphal formation and virulence: is there a clearly defined role. Trends Microbiol. 1998;6(3):92–4.CrossRefPubMedGoogle Scholar
  4. 4.
    Irazoqui JE, Urbach JM, Ausubel FM. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat Rev Immunol. 2010;10(1):47–58.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kim DH, Ausubel FM. Evolutionary perspectives on innate immunity from the study of Caenorhabditis elegans. Curr Opin Immunol. 2005;17(1):4–10.CrossRefPubMedGoogle Scholar
  6. 6.
    Kurz CL, Ewbank JJ. Caenorhabditis elegans: an emerging genetic model for the study of innate immunity. Nat Rev Genet. 2003;4(5):380–90.CrossRefPubMedGoogle Scholar
  7. 7.
    Means TK, et al. Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J Exp Med. 2009;206(3):637–53.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog. 2007;3(7):e101.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Pukkila-Worley R, Mylonakis E. From the outside in and the inside out: antifungal immune responses in Caenorhabditis elegans. Virulence. 2010;1(3):111–2.CrossRefPubMedGoogle Scholar
  10. 10.
    Pukkila-Worley R, Ausubel FM, Mylonakis E. Candida albicans infection of Caenorhabditis elegans induces antifungal immune defenses. PLoS Pathog. 2011;7(6):e1002074.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Aballay A, et al. Cranberry extract standardized for proanthocyanidins promotes the immune response of Caenorhabditis elegans to Vibrio cholerae through the p38 MAPK pathway and HSF-1. PLoS ONE. 2014;9(7):e103290.CrossRefGoogle Scholar
  12. 12.
    Coleman JJ, et al. Antifungal activity of microbial secondary metabolites. PLoS ONE. 2011;6(9):e25321.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tournu H, Serneels J, Van Dijck P. Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets. Curr Drug Targets. 2005;6(8):909–22.CrossRefPubMedGoogle Scholar
  14. 14.
    Breger J, et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 2007;3(2):e18.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Idnurm A, et al. Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS ONE. 2009;4(9):e7025.CrossRefGoogle Scholar
  16. 16.
    Chang W, et al. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production. PLoS ONE. 2012;7(7):e41624.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Zhao LX, et al. Effect of tetrandrine against Candida albicans biofilms. PLoS ONE. 2013;8(11):e79671.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Coleman JJ, et al. Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol. 2010;5(3):321–32.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Falcone PM, et al. Evaluating in vitro antimicrobial activity of thymol toward hygiene-indicating and pathogenic bacteria. J Food Prot. 2007;70(2):425–31.PubMedGoogle Scholar
  20. 20.
    Braga PC, et al. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int J Antimicrob Agents. 2008;31(5):472–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Guo N, et al. Antifungal activity of thymol against clinical isolates of fluconazole-sensitive and -resistant Candida albicans. J Med Microbiol. 2009;58(Pt 8):1074–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Khan A, et al. Effect of two monoterpene phenols on antioxidant defense system in Candida albicans. Microb Pathog. 2015;80:50–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77(1):71–94.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Sun L, Liao K, Wang D. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans. PLoS ONE. 2015;10(2):e0117695.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Sun LM, et al. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans. J Appl Microbiol. 2015;118(4):826–38.CrossRefPubMedGoogle Scholar
  26. 26.
    Larsen B, et al. Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast. 2006;23(11):795–802.CrossRefPubMedGoogle Scholar
  27. 27.
    Sun L, et al. In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother. 2009;53(4):1586–91.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    He K-W, et al. Regulation of aging by unc-13 and sbt-1 in Caenorhabditis elegans is temperature-dependent. Neurosci Bull. 2009;25(6):335–42.CrossRefPubMedGoogle Scholar
  29. 29.
    Wang D, Wang Y, Shen L. Confirmation of combinational effects of calcium with other metals in a paper recycling mill effluent on nematode lifespan with toxicity identification evaluation method. J Environ Sci (China). 2010;22(5):731–7.CrossRefGoogle Scholar
  30. 30.
    Wang D, Xing X. Pre-treatment with mild UV irradiation suppresses reproductive toxicity induced by subsequent cadmium exposure in nematodes. Ecotoxicol Environ Saf. 2010;73(3):423–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Wu Q, et al. Association of oxidative stress with the formation of reproductive toxicity from mercury exposure on hermaphrodite nematode Caenorhabditis elegans. Environ Toxicol Pharmacol. 2011;32(2):175–84.CrossRefPubMedGoogle Scholar
  32. 32.
    Li Y, et al. Transmissions of serotonin, dopamine, and glutamate are required for the formation of neurotoxicity from Al2O3-NPs in nematode Caenorhabditis elegans. Nanotoxicology. 2013;7(5):1004–13.CrossRefPubMedGoogle Scholar
  33. 33.
    Wang D, Xing X. Pre-treatment with mild metal exposure suppresses the neurotoxicity on locomotion behavior induced by the subsequent severe metal exposure in Caenorhabditis elegans. Environ Toxicol Pharmacol. 2009;28(3):459–64.CrossRefPubMedGoogle Scholar
  34. 34.
    Wang D, et al. Methods for creating mutations in C. elegans that extend lifespan. Biol Aging. 2013;1048:65–75.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.College of Life SciencesNanjing Normal UniversityNanjingChina
  2. 2.Institute for Comprehensive Utilization of Wild PlantsNanjingChina
  3. 3.Key Laboratory of Developmental Genes and Human Disease in Ministry of EducationMedical School of Southeast UniversityNanjingChina

Personalised recommendations